Document is current
Any future updates will be listed below
-
Authors
Höfer, Christoph https://orcid.org/0000-0002-3169-3992
Hartikainen, Tau
Lauber, Maria
Maulhardt, Thomas
Oettinger, Vera
Albrecht, Philipp
Maier, Alexander
Zeymer, Uwe
Jäckel, Markus
Westermann, Dirk
von zur Mühlen, Constantin
Rilinger, Jonathan
-
Funding
Funding for this research was provided by:
Universitäts-Herzzentrum Freiburg - Bad Krozingen GmbH
- License Information
-
More Information
Article History
Received: 7 March 2026
Accepted: 17 April 2026
First Online: 4 May 2026
Change Date: 24 May 2026
Change Type: Update
Change Details: Addition to affiliation.
Declarations
:
: This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the local ethics committee of the University of Freiburg (EK-Freiburg 22–1453-S1). Written informed consent was waived by the ethics committee for this retrospective analysis. The study has been registered in the German Clinical Trials Register (DRKS-ID: DRKS00029242).
: Not applicable.
: CH has received speaker’s honoraria from AstraZeneca, independent from this work. TH has received funding from the EAPCI, speaker’s honoraria from Abiomed, AstraZeneca, Amgen, and Novartis, independent from this work.
